CCS-PGO PROGRAMA DE PÓS-GRADUAÇÃO EM ODONTOLOGIA CENTRO DE CIENCIAS DA SAUDE Téléphone/Extension: Indisponible

Banca de DEFESA: DEBORA FACHINELLI NISHI DE SOUZA

Uma banca de DEFESA de DOUTORADO foi cadastrada pelo programa.
STUDENT : DEBORA FACHINELLI NISHI DE SOUZA
DATE: 22/10/2026
TIME: 14:00
LOCAL: Auditório II (DOD)
TITLE:

The role of toothpastes with different active ingredients in peri-implant mucositis: a clinical and laboratory analysis.


KEY WORDS:

Dental Implants; Inflammation; Dentifrices; Chlorhexidine; Enzymes.


PAGES: 144
BIG AREA: Ciências da Saúde
AREA: Odontologia
SUMMARY:

Introduction: Evidence regarding the additional benefits of homecare chemical agents combined with mechanical plaque control following the treatment of peri-implant mucositis remains inconsistent, particularly in the medium and long term. Objectives: To evaluate the effects of toothpastes containing 0.12% chlorhexidine digluconate (CHX) or salivary enzymes (ENZ) as adjuncts to toothbrushing during the maintenance phase following non-surgical treatment of peri-implant mucositis over six months. Additionally, to comprehensively characterize the properties of the toothpastes used in the clinical study to complement the clinical findings. Materials and Methods: Fifty-one individuals (mean age: 56.5 ± 13.7 years) with peri-implant mucositis in at least one implant were included in a randomized, controlled, parallel-group, double-blind clinical trial. Following non-surgical treatment, participants were randomly assigned to the CHX, ENZ, or control (C = fluoride toothpaste) groups and instructed to use the assigned product twice daily for 2 minutes over six months. Plaque index (PI), bleeding on probing (BoP), Lobene Stain Index (LSI), and full-mouth plaque and bleeding scores (FMPS and FMBS, respectively) were assessed at baseline (T0) and after 1 (T1), 3 (T2), and 6 (T3) months. ANOVA, Kruskal–Wallis, and Friedman tests were used (α = 0.05). For the laboratory analyses, the toothpastes underwent physical, chemical, and biological characterization. Antimicrobial activity against Streptococcus mutans, Porphyromonas gingivalis, and Candida albicans was evaluated by determining the minimum inhibitory, minimum bactericidal, and minimum fungicidal concentrations of the complete formulations. Results: All groups showed improvements in clinical parameters over the follow-up period, although no statistically significant differences were observed between the toothpastes. At the implant level, BoP was significantly reduced in all groups compared with baseline. After six months, 24.8% of implants achieved peri-implant health, while those with persistent disease showed a reduction in the number of bleeding sites, indicating decreased disease severity. PI remained significantly lower than baseline through T3 in the CHX and ENZ groups, although no significant differences were observed between groups at six months. FMPS also decreased in all groups, with reductions maintained until the end of follow-up, reaching 26.4%, 30.3%, and 27.1% in the C, CHX, and ENZ groups, respectively (p > 0.05). LSI was similar between the CHX and ENZ groups. In the laboratory analyses, the toothpastes exhibited distinct physicochemical and antimicrobial profiles. C showed greater activity against S. mutans, whereas CHX showed greater activity against P. gingivalis. ENZ exhibited limited antimicrobial activity under the conditions evaluated. Conclusion: All groups showed clinical improvements following non-surgical treatment. Neither CHX nor ENZ toothpaste provided significant additional benefits compared with conventional fluoride toothpaste after six months. Despite the absence of clinical superiority among the formulations, the toothpastes exhibited distinct properties, demonstrating that their performance should be interpreted considering the complete formulation rather than solely the declared active ingredient.


COMMITTEE MEMBERS:
Interno - 90115 - CLEVERSON DE OLIVEIRA E SILVA
Presidente - 125616 - FLAVIA MATARAZZO MARTINS
Externa ao Programa - ***.314.461-** - ISABELLA NEME RIBEIRO DOS REIS - USP
Externo ao Programa - ***.357.299-** - JAIME APARECIDO CURY - UNICAMP
Externa ao Programa - ***.509.548-** - NATÁLIA DE CAMPOS KAJIMOTO - UTSA
Notícia cadastrada em: 09/10/2026 15:45
SIGAA | DAA - Pós-Graduação - (44) 3011-4475 | Copyright © 2006-2026 - UEM - A9-SigaaPA1.srv1inst1